financetom
Business
financetom
/
Business
/
Market Chatter: TikTok Prepares Standalone App for US Users
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: TikTok Prepares Standalone App for US Users
Jul 9, 2025 8:52 AM

11:24 AM EDT, 07/09/2025 (MT Newswires) -- TikTok is readying a standalone app for US users that is expected to operate on a separate data system and algorithm from its global app, Reuters reported Wednesday, citing people familiar with the matter.

TikTok didn't immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LanzaTech Global Increases Stake in LanzaJet to 36% From 23%
LanzaTech Global Increases Stake in LanzaJet to 36% From 23%
Jun 20, 2024
09:50 AM EDT, 06/20/2024 (MT Newswires) -- LanzaTech Global ( LNZA ) said Thursday that it has increased its stake in LanzaJet, a sustainable aviation fuel technology provider and fuels producer, to 36% from 23%. LanzaTech said the move is in accordance with a previous agreement that allowed LanzaJet to further sublicense the alcohol-to-jet technology developed by LanzaTech and others...
ImmunityBio's Bladder Cancer Treatment Anktiva Launches in US
ImmunityBio's Bladder Cancer Treatment Anktiva Launches in US
Jun 20, 2024
09:45 AM EDT, 06/20/2024 (MT Newswires) -- ImmunityBio ( IBRX ) said Thursday that it has launched Anktiva, its immunotherapy to treat Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer, with multiple patients across the US receiving the initial commercial doses. The US Food and Drug Administration approved Anktiva in April to treat patients with BCG-unresponsive non-muscle invasive bladder cancer with or...
Corus Downgraded by S&P on Loss of Warner Bros. Discovery Content
Corus Downgraded by S&P on Loss of Warner Bros. Discovery Content
Jun 20, 2024
09:46 AM EDT, 06/20/2024 (MT Newswires) -- S&P Global Ratings on Wednesday downgraded its issuer credit rating on Corus Entertainment (CJR-B.TO) to B- from B+ after the company this month said some of its programming and trademark output arrangements with Warner Bros. Discovery will not be renewed when they expire on Dec. 31. The negative outlook reflects the overarching risks...
Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14%
Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14%
Jun 20, 2024
09:45 AM EDT, 06/20/2024 (MT Newswires) -- Femasys ( FEMY ) said Thursday it received CE Mark certifications for four of its women's health products, certifying that the products comply with new European Union regulations for medical devices. The company said the CE Mark approvals come on the heels of the products' European Union Medical Device Regulation certificates and will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved